Skip to main content
Up to 53% offSee the plans

News | Stocks | Iran

FTIR Shareholders Approve Doubling Capital Using Retained Earnings

Sahmino Newsroom | 2 November 2026 | 10 days ago

FTIRup3.0%33,780rials11 November

An extraordinary general meeting of Iran Pharmaceutical Injection & Infusion Products Company (ticker FTIR) on Sunday, November 1, 2026 (10 Aban 1405), approved raising capital from 7 trillion rials to 14 trillion rials. According to the minutes posted on Codal that evening, the entire 7 trillion rial increase will be funded from retained earnings, with 7 billion bonus shares of 1,000 rials par value to be issued.

The increase does not require a cash contribution from existing holders, and issuing bonus shares alone does not alter their proportional stake. The company says it will register the increase before the annual meeting for its fiscal year ending in March 2027; assembly approval does not mean registration was completed on the meeting date.

Reference:CodalThe original report

Sahmino context

What the prices have done since this story was published, and what Sahmino wrote around it

Since this story was published, FTIR rose 16 percent, to 33,780 rial.

Over the same days, Tehran Stock Exchange Index rose 10 percent, to 8,427,304.

Over the same days, US Dollar fell 2.7 percent, to 2,640,700 rial.

FTIR
+15.8%
Tehran Stock Exchange Index
+10.2%
US Dollar
−2.7%

Prices to the close of 11 November

More from this market